Stay updated with breaking news from Sara Gianella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An international team including researchers from The University of Texas Health Science Center at San Antonio have developed a novel set of metrics called "immune resilience" (IR) and shown that individuals with optimal levels of IR are more likely to live longer, resist HIV and influenza infections, and survive COVID-19 infections, among outcomes studied.
Multinational study identifies immune resilience as a factor that influences life span, HIV/AIDS, flu, sepsis mortality, recurrent skin cancer, and COVID-19 mortality. Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, toda
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.
April 29, 2021 Jim Dunn, with wife Susan, says that donating his body to research is his way of giving back to the HIV community. Courtesy of Jim Dunn The past few years, Jim Dunn, a 74-year-old living with HIV in San Diego with his wife, Susan, has been struggling with serious skin cancers. Immunotherapy has been holding them at bay, but he acknowledges that his end of life may come faster than he previously thought. And that’s why, about two years ago, he decided to participate in the Last Gift study at University of California-San Diego (UCSD). As part of Last Gift, people with HIV whose...